Kent Imaging Inc. announces a strategic partnership for sales of SnapshotNIR with MellingMedical

A CVE verified Service-Disabled Veteran-Owned Small Business (SDVOSB). MellingMedical currently serves more than 160 VA Medical Centers, 95 Department of Defence Medical Facilities and Health and Human Services (HHS), including Indian Health Services (IHS) and the Center for Disease Control (CDC). MellingMedical has a well-established presence in the federal purchasing system, making available innovative and cost-effective healthcare solutions, including wound care and diabetes management, to America’s veterans, military and other patients of federal health care facilities.

SnapshotNIR demonstrated to be clinically valuable in the management of CLI.

Continuous monitoring of the hemodynamic characteristics (perfusion of oxygenated blood) after revascularization is clinically relevant in monitoring and managing patients with critical limb ischemia (CLI). Handheld SnapshotNIR was used for longitudinal monitoring of tissue oxygenation to predict healing outcomes in patients with CLI at the AZH Wound and Vascular Center, Milwaukee, WI. “The hemodynamic changes measured using SnapshotNIR after endovascular revascularization and HBOT allow clinicians to use this technology to determine treatment protocols and understand healing characteristics in CLI.” Many additional benefits of this imaging technology were noted, including cost effectiveness, time efficiency and ability to integrate with existing EMR. Today’s Wound Clinic® September 2019.

https://www.todayswoundclinic.com/articles/using-near-infrared-spectroscopy-imaging-manage-critical-limb-ischemia